Core Viewpoint - The company reported its 2025 semi-annual results, showing a slight decline in revenue but an increase in net profit, indicating resilience in profitability despite challenging market conditions [1]. Financial Performance - In H1 2025, the company achieved revenue of 1.116 billion yuan, a year-on-year decrease of 1.69%, while net profit attributable to shareholders was 108 million yuan, up 0.22% year-on-year. The non-recurring net profit was 106 million yuan, reflecting a 9.08% increase year-on-year. Earnings per share (EPS) stood at 0.52 yuan [1]. - For Q2 2025, revenue was 572 million yuan, down 1.92% year-on-year but up 5.00% quarter-on-quarter. Net profit for Q2 was 61 million yuan, a year-on-year increase of 17.64% and a quarter-on-quarter increase of 30.77% [1]. Product Performance - The company experienced stable growth in product sales, with a notable increase in the production and sales of dimethyl succinate, while the sales of plasticizers declined [2]. - In H1 2025, the production of dimethyl succinate was 60,300 tons (up 10.98% year-on-year), with sales of 59,700 tons (up 6.01% year-on-year). The production of plasticizers was 26,400 tons (up 0.35% year-on-year), but sales fell to 23,900 tons (down 13.72% year-on-year). The production of fatty alcohols was 25,600 tons (up 6.30% year-on-year), with sales of 26,000 tons (up 12.35% year-on-year) [2]. Pricing and Profitability - Despite a decline in product prices, the overall profit margin improved, primarily due to a greater reduction in raw material costs compared to product prices. The high-margin product PCDL contributed to the overall increase in gross margin [3]. - In H1 2025, the average prices for dimethyl succinate, plasticizers, and fatty alcohols were 7,709 yuan/ton (down 1.50% year-on-year), 8,419 yuan/ton (down 15.79% year-on-year), and 15,369 yuan/ton (down 10.89% year-on-year) respectively. The overall gross margin increased to 17.71%, up 1.12 percentage points year-on-year, while the net margin was 9.64%, up 0.18 percentage points year-on-year [3]. Business Expansion and Capacity - The company is expanding its business and capacity with multiple projects nearing production, including a 35,000 tons/year hindered amine light stabilizer project that has entered trial production, and ongoing construction of a 30,000 tons/year glycol project and a 25,000 tons/year hindered amine light stabilizer project [4]. - As a leading player in niche chemical products, the company is well-positioned to benefit from cyclical market reversals, with a global leading capacity in mixed dimethyl succinate and domestic leading capacity in fatty alcohols and DCP products [4]. Investment Outlook - The company is a leader in the fine chemicals sector, with significant production capacity in dimethyl succinate, fatty alcohols, and DCP products, benefiting from integrated and scaled advantages. The entry into the bio-based sector opens a second growth curve [5]. - Updated revenue forecasts for 2025-2027 are 2.227 billion yuan, 2.760 billion yuan, and 3.513 billion yuan respectively, with net profits of 244 million yuan, 347 million yuan, and 437 million yuan. The corresponding EPS estimates are 1.17 yuan, 1.67 yuan, and 2.10 yuan, with price-to-earnings ratios of 18, 12, and 10 times based on the closing price of 20.82 yuan on September 11 [5].

Core Viewpoint - Yuanli Chemical Group Co., Ltd. has disclosed its key operational data for the first half of 2025, highlighting production, sales, and revenue figures for its main products, as well as price changes for both products and raw materials [1]. Group 1: Key Operational Data - The production and sales figures for the main products in the first half of 2025 are as follows: - Dimethyl Dicarboxylate Series: Production of 60,270.57 tons, Sales of 59,656.35 tons, Revenue of 459.89 million yuan - Plasticizer Series: Production of 26,373.26 tons, Sales of 23,891.33 tons, Revenue of 201.15 million yuan - Fatty Alcohol Series: Production of 25,554.95 tons, Sales of 25,952.46 tons, Revenue of 398.87 million yuan - Total: Production of 112,198.78 tons, Sales of 109,500.14 tons, Revenue of 1,059.91 million yuan [1]. Group 2: Price Changes - The price changes for the main products (excluding tax) are as follows: - Dimethyl Dicarboxylate Series: Price decreased from 7,826.78 yuan/ton to 7,708.99 yuan/ton, a change of -1.50% - Plasticizer Series: Price decreased from 9,997.66 yuan/ton to 8,419.39 yuan/ton, a change of -15.79% - Fatty Alcohol Series: Price decreased from 17,247.54 yuan/ton to 15,369.26 yuan/ton, a change of -10.89% [1]. Group 3: Raw Material Price Changes - The price changes for the main raw materials (excluding tax) are as follows: - 2-Octanol: Price decreased from 10,007.83 yuan/ton to 6,780.00 yuan/ton, a change of -32.25% - Caprolactam: Price decreased from 8,348.73 yuan/ton to 6,502.84 yuan/ton, a change of -22.11% - Normal Butanol: Price decreased from 7,544.20 yuan/ton to 6,017.75 yuan/ton, a change of -20.23% [1].

证券代码：603217 证券简称：元利科技 公告编号：2025-027 元利化学集团股份有限公司 2025 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 元利化学集团股份有限公司（以下简称"公司"）根据上海证券交易所《上 市公司自律监管指引第 3 号行业信息披露第十三号——化工》《关于做好主板上 市公司 2025 年半年度报告披露工作的重要提醒》要求，现将 2025 年半年度主要 经营数据披露如下： | 主要产品 | 产量（吨） | 销量（吨） | 主营业务收入（万元） | | --- | --- | --- | --- | | 二元酸二甲酯系列 | 60,270.57 | 59,656.35 | 45,989.03 | | 增塑剂系列 | 26,373.26 | 23,891.33 | 20,115.03 | | 脂肪醇系列 | 25,554.95 | 25,952.46 | 39,887.00 | | 合计 | 112,198.78 | 109,500.14 | 105,991.06 | ...

二、主要产品和原材料价格变动情况 （一）主要产品的价格变动情况（不含税） 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 元利化学集团股份有限公司（以下简称"公司"）根据上海证券交易所《上 市公司自律监管指引第 3 号行业信息披露第十三号——化工》《关于做好主板上 市公司 2024 年年度报告披露工作的通知》要求，现将 2024 年度主要经营数据披 露如下： | 主要产品 | 产量（吨） | 销量（吨） | 主营业务收入（万元） | | --- | --- | --- | --- | | 二元酸二甲酯系列 | 111,304.42 | 111,717.93 | 87,529.81 | | 增塑剂系列 | 50,436.09 | 52,570.37 | 50,284.36 | | 脂肪醇系列 | 46,864.54 | 45,914.44 | 78,726.13 | 一、2024 年度主要产品的产量、销量及收入实现情况 证券代码：603217 证券简称：元利科技 公告编号：2025-009 元利化学集团股份有限公司 202 ...